These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5773104)
41. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. Foisy MM; Yakiwchuk EM; Chiu I; Singh AE HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946 [TBL] [Abstract][Full Text] [Related]
42. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Revankar SG; Sutton DA; Rinaldi MG Clin Infect Dis; 2004 Jan; 38(2):206-16. PubMed ID: 14699452 [TBL] [Abstract][Full Text] [Related]
43. An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions. Homey B; von Schilling C; Blümel J; Schuppe HC; Ruzicka T; Ahr HJ; Lehmann P; Vohr HW Toxicol Appl Pharmacol; 1998 Nov; 153(1):83-94. PubMed ID: 9875302 [TBL] [Abstract][Full Text] [Related]
44. [Clinical analysis of 410 cases of drug eruption]. Mo BH Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):183, 186. PubMed ID: 12581979 [TBL] [Abstract][Full Text] [Related]
45. Rhinocerebral mucormycosis in patients without predisposing medical conditions: a review of the literature. Elinav H; Zimhony O; Cohen MJ; Marcovich AL; Benenson S Clin Microbiol Infect; 2009 Jul; 15(7):693-7. PubMed ID: 19624514 [TBL] [Abstract][Full Text] [Related]
46. Nitrofurazone toxicity in dairy calves. Fankhauser JA; Bien B; Cottingham R Vet Med Small Anim Clin; 1981 Jun; 76(6):861-2. PubMed ID: 7023014 [No Abstract] [Full Text] [Related]
47. [The use of blood preserved by the mass dilution method in surgical practice]. Dumkin IM Vestn Khir Im I I Grek; 1966 Apr; 96(4):62-4. PubMed ID: 5998648 [No Abstract] [Full Text] [Related]
48. Delayed type hypersensitivity to benzoyl peroxide. Shwereb C; Lowenstein EJ J Drugs Dermatol; 2004; 3(2):197-9. PubMed ID: 15098979 [TBL] [Abstract][Full Text] [Related]
49. [Complications of drug therapy]. Lebedeva GV; Kriukova OI; Zelenina OI; Gess LV; Alekseeva IA Vestn Dermatol Venerol; 1983 May; (5):44-7. PubMed ID: 6224363 [No Abstract] [Full Text] [Related]
50. An update on the role of nitrofurans in the management of urinary tract infections. Guay DR Drugs; 2001; 61(3):353-64. PubMed ID: 11293646 [TBL] [Abstract][Full Text] [Related]
51. Final report on the safety assessment of Triethylene Glycol and PEG-4. Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481 [TBL] [Abstract][Full Text] [Related]
52. Is nitrofurazone a primary irritant or a potent sensitizer? A review of the literature, 1945-1965, and cases reported to the medical director. Glascock HW; MacLeod PF; Davis JB; Cuddihy RV; Anzlowar BR Rev Allergy; 1969 Jan; 23(1):52-8. PubMed ID: 5773104 [No Abstract] [Full Text] [Related]
53. Is nitrofurazone a potent sensitizer in surgical patients? Yilmaz S; Saydam M; Seven E Plast Reconstr Surg; 2004 Sep; 114(3):823-4. PubMed ID: 15318080 [No Abstract] [Full Text] [Related]
54. Topical nitrofurazone, a potent sensitizer of the skin and mucosae. Hull PR; de Beer HA S Afr Med J; 1977 Jul; 52(5):189-90. PubMed ID: 143077 [TBL] [Abstract][Full Text] [Related]
55. [Contact allergy against nitrofurazone (Furacin)]. Braun W; Schütz R Dtsch Med Wochenschr; 1968 Aug; 93(32):1524-6 passim. PubMed ID: 5671139 [No Abstract] [Full Text] [Related]
56. [A case of severe allergic reaction following application of furacillic alcohol in chronic suppurative otitis media]. Gridnev VA Zh Ushn Nos Gorl Bolezn; 1967; 27(6):97-9. PubMed ID: 5622902 [No Abstract] [Full Text] [Related]